Single‐pill combination of cilnidipine, an l‐/n‐type calcium channel blocker, and valsartan reduces the day‐by‐day variability of morning home systolic blood pressure in patients with treated hypertension: A sub‐analysis of the HOPE‐combi survey

We examined the effects of a fixed‐dose single‐pill combination of cilnidipine (10 mg), an L‐/N‐type calcium channel blocker, and valsartan (80 mg) (SPC of Cil/Val) on the day‐by‐day variability of morning home systolic blood pressure (MHSBP) in 616 patients with treated hypertension for 12 months a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kario, Kazuomi, Matsuda, Saori, Nagahama, Shinobu, Kurose, Yoshiki, Sugii, Hitoshi, Teshima, Tsukasa, Suzuki, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029779/
https://www.ncbi.nlm.nih.gov/pubmed/33455076
http://dx.doi.org/10.1111/jch.14178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029779/
https://www.ncbi.nlm.nih.gov/pubmed/33455076
http://dx.doi.org/10.1111/jch.14178

Ejemplares similares